Antenatal thyroid disease and pharmacotherapy in pregnancy

2022 ◽  
pp. 339-355
Author(s):  
Shannon M. Clark ◽  
Luis A. Monsivais
Keyword(s):  
Author(s):  
Dr. Archana Mohana ◽  
Dr. Sujata Badoniya

The Aim of this study is to Review the timing of intervention which will provide the Best Outcome in Hypothyroidism in Pregnancy. Hypothyroid pregnant women are appropriately managed with regular antenatal checkup and thyroxine therapy during pregnancy, a good maternal and fetal outcome can be achieved and congenital cretinism and other neuro developmental sequele in the offspring can be averted. Keywords: Intervention, Hyperthyroidism, Pregnancy & Thyroid disease.


2016 ◽  
Vol 9 (3) ◽  
pp. 126-129 ◽  
Author(s):  
Helen Robinson ◽  
Philip Robinson ◽  
Michael D’Emden ◽  
Kassam Mahomed

Background First-trimester care of maternal thyroid dysfunction has previously been shown to be poor. This study evaluates early management of thyroid dysfunction in pregnancy in Australia. Methods Patients reviewed by the Obstetric Medicine team for thyroid dysfunction from 1 January 2012 to 30 June 2013 were included. Data were collected on gestation at referral from the patient’s general practitioner to the antenatal clinic, information provided in the referral letter, thyroid function tests and thyroid medications. Results Eighty-five women were included in the study. At the time of general practitioner referral to antenatal services, 19% of women with preexisting thyroid disease had no thyroid function tested. Forty-three percent had an abnormal thyroid-stimulating hormone defined as being outside the laboratory-specific pregnancy reference range if available, or outside the level of 0.1–2.5 mIu/L in the first trimester, 0.2–3.0 mIu/L in the second trimester and 0.3–3.0 mIu/L in the third trimester. Only 21% of women increased their thyroxine dose prior to their first antenatal clinic review. Conclusion This study highlights that a significant proportion of women with known thyroid disease either have untested thyroid function in the first trimester or a thyroid-stimulating hormone outside of levels recommended by guidelines.


2002 ◽  
Vol 2 (6) ◽  
pp. 599.2-600 ◽  
Author(s):  
B Vaidya ◽  
M Bilous ◽  
RS Hutchinson ◽  
V Connolly ◽  
S Jones ◽  
...  
Keyword(s):  

2018 ◽  
pp. 479-488
Author(s):  
Yoel Toledano ◽  
Gabriella Solomon
Keyword(s):  

2022 ◽  
Vol 77 (1) ◽  
pp. 45-62
Author(s):  
Ioannis Tsakiridis ◽  
Sonia Giouleka ◽  
Anargyros Kourtis ◽  
Apostolos Mamopoulos ◽  
Apostolos Athanasiadis ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document